Diffuse large B-cell lymphoma

4 · 20 / page

Ask MedXY AI

Latest news

Tag

Hematology-OncologyTumor immune microenvironmentprognostic biomarkers

Decoding the Tumor Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic Insights from CD163 and CD11c Profiling

By MedXY|Aug 11, 2026

This study identifies distinct tumor immune microenvironment subgroups in diffuse large B-cell lymphoma based on CD163 and CD11c expression, revealing prognostic significance and potential therapeutic stratification with checkpoint inhibito

Decoding CD79B Expression Gradient in Diffuse Large B-Cell Lymphoma: Implications for Germinal Center B-Cell Differentiation and Therapeutic Targeting

Hematology-Oncology

Diffuse large B-cell lymphoma

Latest news

Decoding the Tumor Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic Insights from CD163 and CD11c Profiling

Decoding CD79B Expression Gradient in Diffuse Large B-Cell Lymphoma: Implications for Germinal Center B-Cell Differentiation and Therapeutic Targeting

Tisagenlecleucel for Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Clinical Outcomes and Long-Term Follow-Up from the JULIET Trial

Enhancing Patient Experience in DLBCL: Insights from PROs and Clinician-Reported AEs in the Phase 3 POLARIX Trial